Vertical transmission of hepatitis C virus: systematic review and meta-analysis.
Clin Infect Dis. 2014; 59: 765-773
Perinatal transmission of hepatitis C virus.
J Pediatr. 2013; 163 (): 1549
Global prevalence of hepatitis C virus in children in 2018: a modelling study.
Lancet Gastroenterol Hepatol. 2020; 5: 374-392
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Hepatology. 2008; 47: 836-843
Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer.
J Pediatr Hematol Oncol. 2001; 23: 527-529
Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.
J Pediatr. 2007; 150 (): 168-174
Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C.
J Pediatr Gastroenterol Nutr. 2009; 48: 630-635
Health-related quality of life in children with hepatitis C acquired in the first year of life.
J Gastroenterol Hepatol. 2008; 23: 226-230
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes.
J Pediatr Gastroenterol Nutr. 2009; 48: 341-347
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update.
BMJ Open. 2019; 9e027491
Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection.
J Pediatr Gastroenterol Nutr. 2010; 51: 191-197
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
Jama. 2012; 308: 2584-2593
Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990.
Med Decis Making. 2004; 24: 20-29
Canada S. Table 13-10-0114-01 Life expectancy and other elements of the life table, Canada, all provinces except Prince Edward Island 2018 [cited 2013-2015.
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
J Hepatol. 2006; 44: 217-231
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009; 27: 1485-1491
Predictors of patient and graft survival following liver transplantation for hepatitis C.
Hepatology. 1998; 28: 823-830
Hunink MGM, et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Second Edition ed. Cambridge, United Kingdom: Cambridge University Press; 2014. 424 p.
A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C.
Value Health. 2020; 23: 127-137
Haines A YZ, Thein H, Wong W, Krahn M. State-specific direct medical costs of hepatitis C in Ontario: A population-level study 2019 [Available from: https://canlivj.utpjournals.press/doi/full/10.3138/canlivj.2019-abstract.
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
PLoS One. 2018; 13e0201120
Table 18-10-0005-01 Consumer Price Index, annual average, not seasonally adjusted [Internet]. Statistics Canada. 2020 [cited Feb 5, 2020]. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1810000501.
Wodchis WP, Bushmeneva K, Nikitovic M, McKillop I. Guidelines on person-level costing using administrative databases in Ontario. 2013.
Secrecy on cost of publicly funded hep C treatment.
Cmaj. 2017; 189 ()
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.
Hepatology. 2017; 66: 371-378
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
Hepatology. 2018; 68: 2158-2166
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study.
Hepatology. 2020; 71: 456-462
Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold.
N Engl J Med. 2014; 371: 796-797
Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection.
J Pediatr. 2019; 207: 90-96
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
Hepatology. 2020; 71: 686-721
Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.
JAMA internal medicine. 2016; 176: 65-73